Valuation: Yuhan Corporation

Capitalization 8,733B 5.91B 5.04B 4.7B 4.43B 8.15B 535B 8.9B 54.9B 21.3B 252B 22.18B 21.71B 921B P/E ratio 2025 *
72.2x
P/E ratio 2026 * 55.4x
Enterprise value 8.64B 5.85M 4.98M 4.65M 4.38M 8.06M 530M 8.81M 54.31M 21.07M 250M 21.94M 21.48M 911M EV / Sales 2025 *
3.85x
EV / Sales 2026 * 3.5x
Free-Float
67.64%
Yield 2025 *
0.42%
Yield 2026 * 0.43%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.86%
1 week-0.26%
Current month-4.10%
1 month-6.40%
3 months-2.26%
6 months+9.86%
Current year-2.09%
More quotes
1 week 115,600
Extreme 115600
117,500
1 month 114,200
Extreme 114200
125,500
Current year 100,400
Extreme 100400
140,700
1 year 100,400
Extreme 100400
140,700
3 years 47,571.43
Extreme 47571.4286
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
More quotes
Manager TitleAgeSince
Chief Executive Officer 70 2021-03-18
Director of Finance/CFO 57 -
President 66 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 70 2015-03-19
Director/Board Member 61 2020-02-29
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.86%-0.26%-2.34%+116.07% 5.91B
-0.38%-1.86%-16.12%-36.55% 60.15B
+0.78%+2.08%+7.86%-17.02% 8.58B
+0.50%-1.77%+29.60%+6.31% 7.32B
-1.84%-0.60%+25.78%+71.65% 7.06B
-0.64%+1.25%+207.35%+61.64% 4.44B
-0.87%+0.06%-12.77%-6.82% 2.84B
+1.40%+3.24%+30.38%+32.58% 2.7B
+0.87%-1.80%+19.19%+45.66% 2.5B
+0.10%-0.77%-16.39%+4.81% 1.95B
Average +0.07%-0.16%+27.26%+27.83% 10.35B
Weighted average by Cap. -0.19%-1.18%+4.50%-6.19%
See all sector performances

Financials

2025 *2026 *
Net sales 2,242B 1.52B 1.29B 1.21B 1.14B 2.09B 137B 2.29B 14.1B 5.47B 64.8B 5.69B 5.57B 236B 2,436B 1.65B 1.4B 1.31B 1.23B 2.27B 149B 2.48B 15.31B 5.94B 70.38B 6.19B 6.06B 257B
Net income 131B 88.71M 75.58M 70.6M 66.42M 122M 8.04B 134M 824M 320M 3.79B 333M 326M 13.82B 163B 110M 94.05M 87.85M 82.65M 152M 10B 166M 1.03B 398M 4.71B 414M 405M 17.2B
Net Debt -93.57B -63.33M -53.95M -50.4M -47.42M -87.3M -5.74B -95.37M -588M -228M -2.7B -238M -233M -9.86B -206B -140M -119M -111M -105M -192M -12.64B -210M -1.3B -503M -5.96B -524M -513M -21.75B
More financial data * Estimated data
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of non-prescription drugs including anti-inflammatory drugs, as well as prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and Health segment is involved in the production and sale of household goods and animal healthcare (AHC) products, including bleach, antibacterial agents. The Overseas Business segment supplies raw drugs to domestic and overseas markets. The Company also sells licenses. The Company distributes its products in domestic and overseas markets such as Europe, Asia and United States.
Employees
2,067
More about the company
Date Price Change Volume
25-12-12 117,000.00 +0.86% 287,451
25-12-11 116,000.00 +0.09% 424,947
25-12-10 115,900.00 -0.52% 199,445
25-12-09 116,500.00 +0.34% 228,450
25-12-08 116,100.00 -1.02% 330,202

End-of-day quote Korea S.E., December 11, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
117,000.00KRW
Average target price
148,388.89KRW
Spread / Average Target
+26.83%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A000100 Stock